Latest Insider Transactions at Baxter International Inc (BAX)
This section provides a real-time view of insider transactions for Baxter International Inc (BAX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BAXTER INTERNATIONAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BAXTER INTERNATIONAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2024
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
32,884
+20.52%
|
-
|
|
Feb 12
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,311
-3.55%
|
$52,440
$40.31 P/Share
|
|
Feb 12
2024
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,184
+10.17%
|
-
|
|
Dec 01
2023
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
13,994
+20.72%
|
-
|
|
Dec 01
2023
|
Joel T. Grade EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53,177
+41.07%
|
-
|
|
Sep 01
2023
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,016
+27.11%
|
-
|
|
Sep 01
2023
|
Alok Sonig EVP,Group President, Pharma |
SELL
Payment of exercise price or tax liability
|
Direct |
2,059
-6.13%
|
$82,360
$40.6 P/Share
|
|
Aug 21
2023
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,049
+50.0%
|
-
|
|
Jun 29
2023
|
William A. Ampofo Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,811
+50.0%
|
-
|
|
Jun 01
2023
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
5,909
+13.16%
|
-
|
|
Jun 01
2023
|
Christopher A. Toth EVP,Group Pres, Kidney Care |
BUY
Grant, award, or other acquisition
|
Direct |
106,358
+50.0%
|
-
|
|
Jun 01
2023
|
David S. Rosenbloom EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
762
-1.35%
|
$31,242
$41.23 P/Share
|
|
May 02
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+36.09%
|
-
|
|
May 02
2023
|
David Brent Shafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+39.17%
|
-
|
|
May 02
2023
|
Cathy R Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+22.09%
|
-
|
|
May 02
2023
|
David S. Wilkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+31.31%
|
-
|
|
May 02
2023
|
Peter M Wilver Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+39.14%
|
-
|
|
May 02
2023
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+32.06%
|
-
|
|
May 02
2023
|
Patricia Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+23.38%
|
-
|
|
May 02
2023
|
Stephen N. Oesterle Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+17.65%
|
-
|
|
May 02
2023
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,573
+20.35%
|
-
|
|
Mar 20
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.49%
|
$6,118
$38.19 P/Share
|
|
Mar 20
2023
|
Albert P L Stroucken Director |
SELL
Open market or private sale
|
Direct |
3,930
-9.64%
|
$145,410
$37.52 P/Share
|
|
Mar 20
2023
|
Albert P L Stroucken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,930
+8.79%
|
$141,480
$36.93 P/Share
|
|
Mar 20
2023
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.4%
|
$8,056
$38.19 P/Share
|
|
Mar 20
2023
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-0.56%
|
$5,738
$38.19 P/Share
|
|
Mar 03
2023
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.41%
|
$8,580
$39.94 P/Share
|
|
Mar 03
2023
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.55%
|
$5,772
$39.94 P/Share
|
|
Mar 03
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.55%
|
$7,176
$39.94 P/Share
|
|
Mar 02
2023
|
Jose E Almeida Chairman, CEO, President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,642
-1.12%
|
$181,038
$39.62 P/Share
|
|
Mar 02
2023
|
James W Borzi EVP,Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-2.31%
|
$18,486
$39.62 P/Share
|
|
Mar 02
2023
|
Cristiano Franzi SVP, President, EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.14%
|
$5,694
$39.62 P/Share
|
|
Mar 02
2023
|
Heather Knight EVP,Group Pres,Med Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-1.95%
|
$41,613
$39.62 P/Share
|
|
Mar 02
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
271
-1.18%
|
$10,569
$39.62 P/Share
|
|
Mar 02
2023
|
Jeanne K Mason EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
460
-0.33%
|
$17,940
$39.62 P/Share
|
|
Mar 02
2023
|
Reaz Rasul EVP,Group Pres, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-1.51%
|
$16,224
$39.62 P/Share
|
|
Mar 02
2023
|
James Saccaro EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-0.59%
|
$41,379
$39.62 P/Share
|
|
Mar 02
2023
|
Brian Stevens SVP, CAO & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-1.24%
|
$16,302
$39.62 P/Share
|
|
Mar 01
2023
|
James Saccaro EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,217
+11.04%
|
-
|
|
Mar 01
2023
|
Brian Stevens SVP, CAO & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
6,788
+16.78%
|
-
|
|
Mar 01
2023
|
Heather Knight EVP,Group Pres,Med Products |
BUY
Grant, award, or other acquisition
|
Direct |
21,600
+28.34%
|
-
|
|
Mar 01
2023
|
Reaz Rasul EVP,Group Pres, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
15,428
+35.95%
|
-
|
|
Mar 01
2023
|
Alok Sonig EVP,Group President, Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
15,428
+31.71%
|
-
|
|
Mar 01
2023
|
Jose E Almeida Chairman, CEO, President |
BUY
Grant, award, or other acquisition
|
Direct |
67,884
+14.11%
|
-
|
|
Mar 01
2023
|
James W Borzi EVP,Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,640
+29.6%
|
-
|
|
Mar 01
2023
|
Steven Flynn SVP, President, APAC |
BUY
Grant, award, or other acquisition
|
Direct |
18,514
+26.6%
|
-
|
|
Mar 01
2023
|
Cristiano Franzi SVP, President, EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
40,113
+18.01%
|
-
|
|
Mar 01
2023
|
Jacqueline Kunzler SVP, Chief Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,171
+21.23%
|
-
|
|
Mar 01
2023
|
Jeanne K Mason EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,491
+7.0%
|
-
|
|
Mar 01
2023
|
David S. Rosenbloom EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
13,885
+19.84%
|
-
|